University of Helsinki
🇫🇮Finland
- Country
- 🇫🇮Finland
- Ownership
- Private
- Established
- 1640-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.helsinki.fi
Lactobacillus Rhamnosus in Prevention of Chemotherapy-related Diarrhoea
Not Applicable
Completed
- Conditions
- Colorectal Cancer
- Interventions
- Dietary Supplement: Lactobacillus Rhamnosus supplementationOther: Placebo administration.
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2021-11-24
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 84
- Registration Number
- NCT00197873
- Locations
- 🇫🇮
Department of Oncology, Helsinki, Finland
TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Dietary Supplement: Hydrolysed infant formulaDietary Supplement: Nonhydrolysed infant formula
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2021-07-30
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 5156
- Registration Number
- NCT00179777
- Locations
- 🇺🇸
The University of South Florida, Tampa, Florida, United States
🇦🇺Children's Hospital at Westmead, Westmead, New South Wales, Australia
🇨🇦Robarts Research Institute, London, Ontario, Canada
PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
- First Posted Date
- 2005-07-06
- Last Posted Date
- 2010-05-27
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 45
- Registration Number
- NCT00117299
- Locations
- 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
- First Posted Date
- 2005-06-27
- Last Posted Date
- 2018-03-02
- Lead Sponsor
- University of Helsinki
- Target Recruit Count
- 160
- Registration Number
- NCT00115895
- Locations
- 🇫🇮
Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland
© Copyright 2025. All Rights Reserved by MedPath